NIAID Research Education Program (R25 Clinical Trial Not Allowed) | PAR 20 289

Opportunity Information: Apply for PAR 20 289

The NIAID Research Education Program (R25 Clinical Trial Not Allowed), funding opportunity number PAR-20-289, is a discretionary NIH grant opportunity designed to support research education activities that align with the mission areas of the National Institute of Allergy and Infectious Diseases (NIAID). The core purpose of the R25 mechanism in this context is educational rather than direct research project support: it funds structured programs that educate, prepare, and strengthen the workforce needed to meet the United States' biomedical, behavioral, and clinical research demands in areas relevant to NIAID. In practical terms, applicants propose educational experiences that complement and/or enhance existing training pathways, with an emphasis on developing skills, knowledge, and career readiness for participants who are moving toward research-focused careers connected to NIAID priorities.

This opportunity uses the NIH grant funding instrument and falls under the health funding activity category (CFDA 93.855). While the notice emphasizes workforce development, it is explicitly designated "Clinical Trial Not Allowed," meaning the supported activities must not include proposing or conducting clinical trials as part of the application. Programs can still be strongly clinically relevant in terms of education and training, but they must stay within NIH's definition of non-clinical-trial activities (for example, educational curricula, skills development workshops, mentored educational experiences, and other research education components that do not constitute a clinical trial).

A wide range of domestic organizations are eligible to apply. Eligible applicant types include state, county, and city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; Native American tribal governments (federally recognized); tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; and both nonprofit organizations (with or without 501(c)(3) status) and for-profit organizations (other than small businesses), as well as small businesses. The opportunity also highlights additional eligible applicant categories that reflect an interest in broad participation across institutions and communities, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, certain tribal governments (other than federally recognized), regional organizations, eligible federal agencies, and U.S. territories or possessions.

At the same time, there are firm restrictions related to foreign involvement. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply, non-domestic components of U.S. organizations are not eligible, and foreign components (as defined by the NIH Grants Policy Statement) are not allowed under this announcement. In other words, the applicant organization and the funded program activities must be structured as fully domestic efforts under NIH policy, without foreign components.

The posted award ceiling is $325,000, indicating the maximum amount that can be awarded under the announcement (as provided in the source data). The record shows an original closing date of March 15, 2022, and a creation date of September 17, 2020. Overall, this funding opportunity is aimed at institutions and organizations that can design and deliver high-quality research education programming to build capacity and preparedness in NIAID-relevant fields, while staying clearly outside the boundaries of clinical trial activity and meeting NIH eligibility and foreign component restrictions.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIAID Research Education Program (R25 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855.
• This funding opportunity was created on 2020-09-17.
• Applicants must submit their applications by 2022-03-15. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $325,000.00 in funding.
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 20 289

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: